; composition (A) Establishment There is hereby established for the One Hundred Eighteenth Congress a select investigative subcommittee of the Committee on Oversight and Accountability called the Select Subcommittee on the Coronavirus Pandemic (hereinafter referred to as the select subcommittee ). (B) Composition (i) The select subcommittee shall be composed of not more than 12 Members, Delegates, or the Resident Commissioner appointed by the Speaker, of whom not more than 5 shall be appointed in consultation with the Minority Leader. The Speaker shall designate one member of the select subcommittee as its chair. Any vacancy in the select subcommittee shall be filled in the same manner as the original appointment. (ii) The chair and ranking minority member of the Committee on Oversight and Accountability shall be ex officio members of the select subcommittee but shall have no vote in the select subcommittee and may not be counted for purposes of determining a quorum. (iii) Each member appointed to the select subcommittee shall be treated as though a member of the Committee on Oversight and Accountability for purposes of the select subcommittee. (2) Investigative functions and authority (A) Investigative functions The select subcommittee is authorized and directed to conduct a full and complete investigation and study and, not later than January 2, 2025, issue a final report to the House of its findings (and such interim reports as it may deem necessary) regarding— (i) the origins of the Coronavirus pandemic, including but not limited to the Federal Government’s funding of gain-of-function research; (ii) the efficiency, effectiveness, and transparency of the use of taxpayer funds and relief programs to address the coronavirus pandemic, including any reports of waste, fraud, or abuse; (iii) the implementation or effectiveness of any Federal law or regulation applied, enacted, or under consideration to address the coronavirus pandemic and prepare for future pandemics